Jan. 22, 2014
For an updated post on this subject, click here. By David H. Kirkwood ROCKVILLE, MD–A U.S. Food and Drug Administration (FDA) proposal to tighten existing restrictions on the marketing of personal sound amplification products (PSAPs) is arousing both a storm of criticism and strong support from various interested parties. Although the February 5 deadline for submitting responses to FDA’s proposed